Related Experiment Video
Updated: May 20, 2026

14:39
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Trihydroxyflavones with antioxidant and anti-inflammatory efficacy
Ana Gomes1, Diana Couto, Andreia Alves
1REQUIMTE, Departamento de Ciências Químicas, Universidade do Porto, Porto, Portugal.
Biofactors (Oxford, England)
|July 19, 2012
Summary
Trihydroxyflavones show potent anti-inflammatory effects by scavenging reactive oxygen and nitrogen species. One compound, 3,5,7-trihydroxyflavone, acts as a dual inhibitor of cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) pathways.
Area of Science:
- Pharmacology
- Medicinal Chemistry
Background:
- Classical anti-inflammatory therapies often cause severe side effects and limited efficacy.
- Novel anti-inflammatory agents with distinct mechanisms are needed.
- Hydroxyflavones possess antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To evaluate the anti-inflammatory potential of trihydroxyflavones.
- To assess their ability to scavenge reactive oxygen species (ROS) and reactive nitrogen species (RNS).
- To investigate their inhibitory effects on cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) pathways.
Main Methods:
- Testing trihydroxyflavones' ROS/RNS scavenging in cell-free and cellular systems.
- Assessing inhibition of neutrophils' oxidative burst.
- Evaluating inhibition of leukotriene B(4) production by 5-LOX.
- Determining COX-1 and COX-2 inhibition.
Main Results:
- Trihydroxyflavones effectively inhibited neutrophils' oxidative burst and scavenged ROS/RNS.
- 3,3',4'-trihydroxyflavone demonstrated significant free radical scavenging activity.
- Compounds inhibited 5-LOX mediated leukotriene B(4) production.
- 3,5,7-trihydroxyflavone inhibited both COX-1 and COX-2.
Conclusions:
- Trihydroxyflavones exhibit promising anti-inflammatory properties.
- 3,3',4'-trihydroxyflavone is a potent antioxidant and free radical scavenger.
- 3,5,7-trihydroxyflavone offers a dual inhibition of COX and 5-LOX pathways, presenting a novel therapeutic candidate.
